-
Six Proteins Upregulated Years Before Ulcerative Colitis Diagnosis
Drugs
November 25, 2021
Six inflammatory proteins are upregulated in plasma several years before diagnosis of ulcerative colitis, according to a report published in the November issue of Gastroenterology.
-
GTP Bioways to galvanise CDMO position in France with two new biopharma facilities
CPhIonline
October 29, 2021
The specialist biotherapies and nanotherapies producer has said the first line, which will have a capacity of 300 L, will focus on production using microbial systems (bacteria and yeast), and will be operational in early 2023.
-
Study reveals how coronavirus could hijack human cells
expresspharma
February 18, 2021
Scientists, including one of Indian-origin, have identified parts of human proteins which thehuman proteins could be using to hijack host cell processes, an advance that may lead to the development of new drugs for treating COVID-19.
-
How SARS-CoV-2 interacts with cells
worldpharmanews
December 23, 2020
SARS-CoV-2 infections pose a global threat to human health and a formidable research challenge. One of the most urgent tasks is to gain a detailed understanding of the molecular interactions between the virus and the cells it infects.
-
Existing drugs can prevent SARS-CoV-2 from hijacking cells
worldpharmanews
June 30, 2020
An international team of researchers has analysed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins in its target cells.
-
Pfenex, Arcellx Announce Development, Evaluation and License Agreement
contractpharma
August 02, 2019
Arcellx gains access to Pfenex Expression Technology® platform to advance multiple proprietary sparX proteins.
-
Relay Therapeutics bags $400M to ramp up discovery and push into the clinic
fiercebiotech
December 25, 2018
Two weeks after expanding its R&D team, Relay Therapeutics is reeling in a massive $400 million series C round to boost its platform technology and discovery efforts, build its pipeline and get into the clinic......
-
Novo begins R&D tie-up with AI biotech e-Therapeutics
pharmaphorum
December 13, 2018
Novo Nordisk has signed a deal with UK biotech e-Therapeutics to use its AI-based drug discovery technology to find new therapies for type 2 diabetes.
-
2 proteins show promise as targets for treating obesity
fiercebiotech
August 23, 2018
The human body has intricate methods for regulating fat storage and maintaining weight. But sometimes those mechanisms fail to work properly, particularly in the context of a high-fat diet, or they actually counteract attempts to lose weight.
-
AGC Biologics Expands Capacity at Berkeley, California Facility
prnasia
March 07, 2018
AGC Biologics, announced today that their Berkeley, California facility is adding to its growing capacity with the addition of a 2000L single-use bioreactor (SUB).